Eptinezumab
(Anti-human CGRP mAb, human IgG1 N297A-Kappa; ALD-403)
Catalog No.: PC-Ab1049Not For Human Use, Lab Use Only.
Eptinezumab (ALD-403) is a humanized monoclonal antibody to calcitonin gene like peptide (CGLP) which is used in the prevention of migraine headaches. Eptinezumab binds to alpha and beta forms of the CGRP ligand, preventing the ligand from binding to the receptor and blocking CGRP’s downstream effects, like pain transmission..
Eptinezumab (ALD-403) is a humanized monoclonal antibody to calcitonin gene like peptide (CGLP) which is used in the prevention of migraine headaches. Eptinezumab binds to alpha and beta forms of the CGRP ligand, preventing the ligand from binding to the receptor and blocking CGRP’s downstream effects, like pain transmission.
Physicochemical Properties
M.Wt
Formula
Human IgG1 N297A-Kappa
Appearance
Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility
PBS, pH 7.0
Contains no stabilizers or preservatives
